e-learning
resources
Conferences
6th Sleep and Breathing Conference, Online 2021
2021
16.04.2021
Treatment and management of sleep respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
C. CAUSSE (Paris, France), J. Pépin (Grenoble, France), Y. Dauvilliers (Montpelliers, France), V. Attali (Paris, France), P. Lehert (Mons, Belgium)
Source:
Sleep and Breathing Conference 2021
Session:
Treatment and management of sleep respiratory diseases
Session type:
Oral Presentation
Number:
0
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. CAUSSE (Paris, France), J. Pépin (Grenoble, France), Y. Dauvilliers (Montpelliers, France), V. Attali (Paris, France), P. Lehert (Mons, Belgium). Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea. Sleep and Breathing Conference 2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Related content which might interest you:
Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
Daytime sleepiness in patients with treated obstructive sleep apnea
Source: Eur Respir J 2007; 30: Suppl. 51, 594s
Year: 2007
Diagnosing excessive daytime sleepiness in obstructive sleep apnoea
Source: 5th Sleep and Breathing Conference
Year: 2019
Daytime sleepiness and quality of life in patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021
Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms
Source: Eur Respir J 2011; 37: 98-105
Year: 2011
Sleep architecture in patients with moderate to severe sleep apnea without daytime sleepiness
Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation
Year: 2007
Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome
Source: Eur Respir J 2001; 17: 838-847
Year: 2001
Determinants of subjective sleepiness in suspected obstructive sleep apnoea
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
What is the impact of obstructive sleep apnea hypopnea syndrome and daytime sleepiness on work performance?
Source: International Congress 2017 – Variation in th phenotypes and symptoms of obstructive sleep apnoea
Year: 2017
Differences in the daytime sleepiness between sleep apnoea and hypersomnia patients
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
The frequency of REM related OSA among patients with mild OSA and the relation between apnea and daytime sleepiness among these patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Effects of solriamfetol on real-world driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
Source: Sleep and Breathing Conference 2021
Year: 2021
Efficacy of adaptive servo-ventilation on residual sleepiness in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea
Year: 2008
Obesity and daytime somnolence at patients with obstructive sleep apnea and sistemic hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 562s
Year: 2002
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002
Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment
Source: Eur Respir J 2013; 41: 593-600
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept